Stay updated with breaking news from Zymeworks Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Zymeworks Inc. (NYSE:ZYME – Get Rating) rose 4.7% on Wednesday . The company traded as high as $9.42 and last traded at $9.42. Approximately 52,952 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 690,268 shares. The stock had previously closed at $9.00. Wall Street Analyst […]
VANCOUVER, British Columbia — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today…
Zymeworks Inc. (NYSE:ZYME – Get Rating)’s share price rose 2.7% during mid-day trading on Wednesday . The stock traded as high as $9.66 and last traded at $9.65. Approximately 27,345 shares were traded during trading, a decline of 96% from the average daily volume of 688,124 shares. The stock had previously closed at $9.40. Analyst […]
Zymeworks (NYSE:ZYME – Get Rating) had its price objective raised by JPMorgan Chase & Co. from $8.00 to $9.00 in a report published on Friday, Benzinga reports. They currently have a neutral rating on the stock. A number of other research analysts also recently weighed in on the company. Jefferies Financial Group raised Zymeworks from […]
Zymeworks Inc. , a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor... | April 3, 2023